Meghana V. Trivedi

Baylor College of Medicine — United States

Medicine · Health Sciences

25h-index2.6kcitations179works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(39), HER2/EGFR in Cancer Research(34), Estrogen and related hormone effects(31), Advanced Breast Cancer Therapies(22), Medication Adherence and Compliance(16)

Publications177 total

Interventions to improve adherence to oral endocrine therapy for prevention or treatment of breast cancer in Black women of low socioeconomic status
Supportive Care in Cancer·2025
Identification of factors associated with non-adherence to oral endocrine therapy in breast cancer patients of low socioeconomic status: a single centre retrospective study
International Journal of Clinical Pharmacy·2025
Targeting the IRE1α/XBP1 Signaling Axis Suppresses Rhabdomyosarcoma Growth and Promotes Myogenic Differentiation
2025Open Access
TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma
2025Open Access
1051 Prediction of severe immune-related adverse events among real-world patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a SEER-medicare analysis
Regular and Young Investigator Award Abstracts·2025Open Access
Group-Based Trajectory Modeling for Assessing Oral Endocrine Therapy Adherence Pattern in HER-positive Breast Cancer Patients at DHR Health in the Rio Grande Valley
Research in Social and Administrative Pharmacy·2025Open Access
Group-Based Trajectory Model to Assess Adjuvant Endocrine Therapy Adherence Pattern in HR-Positive Breast Cancer: Results from Rio Grande Valley Patients
Healthcare·2025· 1 citedOpen Access
The TWEAK/Fn14 signaling mediates skeletal muscle wasting during cancer cachexia
iScience·2025· 6 citedOpen Access
Abstract 515: Repurposing nebivolol with dasatinib and CPI-613: A synergistic strategy to combat triple-negative breast cancer
Cancer Research·2025
Abstract 2027: Developing an image analysis algorithm to evaluate immunofluorescence intensity for Rb and phospho-Rb expression in circulating tumor cells in HR+/HER2- breast cancer
Cancer Research·2025
Abstract 4347: Preclinical evaluation of pharmacokinetic interactions among nebivolol, dasatinib and devimistat in mice
Cancer Research·2025· 1 cited
Non-adherence of cyclin-dependent kinases 4 and 6 inhibitors reduces overall and progression-free survival in patients with hormone receptor–positive breast cancer
Breast Cancer Research and Treatment·2025· 3 cited
Group-Based Trajectory Modeling to Identify Patterns and Predictors of Adherence to Oral Endocrine Therapies in Underserved Population of Greater Houston Area
Patient Preference and Adherence·2025Open Access
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2‐positive breast cancer
British Journal of Pharmacology·2025· 5 citedOpen Access
Drug safety alerts for childhood cancer medicines in India from CDSCO(2021-2025) and PvPI notifications (2016–2025)
Pediatric Hematology Oncology Journal·2025Open Access
The TWEAK/Fn14 signaling promotes skeletal muscle wasting during cancer cachexia
2024Open Access
Factors associated with the use of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study
Journal of Geriatric Oncology·2024
Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective study
Supportive Care in Cancer·2024· 1 cited
HSD75 Factors Associated With the Use of Immune Checkpoint Inhibitors in Older Adults With Metastatic Non-Small Cell Lung Cancer and Pre-Existing Autoimmune Disease: A SEER-Medicare Study
Value in Health·2024
Abstract PO3-09-09: Interventions to improve adherence to oral endocrine therapy for prevention or treatment of breast cancer in African American women of low socioeconomic status
Cancer Research·2024
page 1 of 9Next →

Frequent Co-authors

Rachel Schiff(19), Carmine De Angelis(15), Raksha R. Bhat(14), Mario Giuliano(13), C. Kent Osborne(12), Mothaffar F. Rimawi(9), Agostina Nardone(8), Xiaoyong Fu(7), Carolina Gutiérrez(6), Susan G. Hilsenbeck(6), Susan Abughosh(6), Noor Mazin Abdulkareem(6), Sabino De Placido(5), Rinath Jeselsohn(5), Chad J. Creighton(5), Martin J. Shea(5), Hariprasad Thangavel(5), Sarmistha Nanda(5), Grazia Arpino(4), Sufeng Mao(4)